226 related articles for article (PubMed ID: 9650098)
1. Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis.
Sedivá A; Bartůnková J; Kolárová I; Hrusák O; Vávrová V; Macek M; Lockwood CM; Dunn AC
J Autoimmun; 1998 Apr; 11(2):185-90. PubMed ID: 9650098
[TBL] [Abstract][Full Text] [Related]
2. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
3. Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI.
Schultz H; Csernok E; Schuster A; Schmitz TS; Ernst M; Gross WL
Pediatr Allergy Immunol; 2000 May; 11(2):64-70. PubMed ID: 10893006
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibodies in children.
Sedivá A; Kolárová I; Bartůnková J
Eur J Pediatr; 1998 Dec; 157(12):987-91. PubMed ID: 9877037
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis.
Zhao MH; Jayne DR; Ardiles LG; Culley F; Hodson ME; Lockwood CM
QJM; 1996 Apr; 89(4):259-65. PubMed ID: 8733512
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies.
Carlsson M; Eriksson L; Erwander I; Wieslander J; Segelmark M
Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S95-100. PubMed ID: 14740434
[TBL] [Abstract][Full Text] [Related]
7. BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.
Lindberg U; Carlsson M; Hellmark T; Segelmark M
J Immunol Res; 2015; 2015():947934. PubMed ID: 26273683
[TBL] [Abstract][Full Text] [Related]
8. Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects.
Audrain MA; Sesboüé R; Baranger TA; Elliott J; Testa A; Martin JP; Lockwood CM; Esnault VL
Nephrol Dial Transplant; 2001 Jan; 16(1):39-44. PubMed ID: 11208991
[TBL] [Abstract][Full Text] [Related]
9. Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease.
Mahadeva R; Dunn AC; Westerbeek RC; Sharples L; Whitehouse DB; Carroll NR; Ross-Russell RI; Webb AK; Bilton D; Lomas DA; Lockwood CM
Clin Exp Immunol; 1999 Sep; 117(3):561-7. PubMed ID: 10469063
[TBL] [Abstract][Full Text] [Related]
10. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies.
Bartůnková J; Tesar V; Sedivá A
Clin Immunol; 2003 Feb; 106(2):73-82. PubMed ID: 12672398
[TBL] [Abstract][Full Text] [Related]
12. Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis.
Dorlöchter L; Carlsson M; Olafsdottir EJ; Røksund OD; Rosendahl K; Fluge G
J Cyst Fibros; 2004 Aug; 3(3):179-83. PubMed ID: 15463905
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations.
Manolova I; Dancheva M; Halacheva K
Rheumatol Int; 2001 Jul; 20(5):197-204. PubMed ID: 11518040
[TBL] [Abstract][Full Text] [Related]
14. BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitro.
Schultz H; Schinke S; Mosler K; Herlyn K; Schuster A; Gross WL
Pediatr Pulmonol; 2004 Feb; 37(2):158-64. PubMed ID: 14730661
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein detected in children with cystic fibrosis inhibit neutrophil-mediated killing of Pseudomonas aeruginosa.
Sedivá A; Bartůnková J; Bartosová J; Jennette C; Falk RJ; Jethwa HS
Microbes Infect; 2003 Jan; 5(1):27-30. PubMed ID: 12593970
[TBL] [Abstract][Full Text] [Related]
18. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
Schultz H; Weiss J; Carroll SF; Gross WL
J Leukoc Biol; 2001 Apr; 69(4):505-12. PubMed ID: 11310835
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.
Merkel PA; Polisson RP; Chang Y; Skates SJ; Niles JL
Ann Intern Med; 1997 Jun; 126(11):866-73. PubMed ID: 9163287
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa in cystic fibrosis: pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease.
Carlsson M; Shukla S; Petersson AC; Segelmark M; Hellmark T
J Cyst Fibros; 2011 Jul; 10(4):265-71. PubMed ID: 21463973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]